Micron Technology, Inc. (Nasdaq: MU) files with the SEC as a Delaware corporation headquartered in Boise, Idaho, and its filings follow a fiscal year that ends in late August or early September. Quarterly reports on Form 10-Q carry the financial statements together with revenue by technology, goodwill for each of the four business units, customer concentration, stock-based compensation, and property and equipment that includes equipment not yet placed into service.
The quarterly reports also document the expansion of Micron’s manufacturing base, including government incentive arrangements for its Singapore manufacturing and research facilities and the completed acquisition of a wafer fabrication facility in Tongluo, Taiwan, from Powerchip Semiconductor Manufacturing Corporation.
Current reports on Form 8-K carry the quarterly and full-year results press releases under Item 2.02, officer appointments and new directors under Item 5.02, amendments to the certificate of incorporation under Item 5.03, and annual meeting vote results under Item 5.07. Micron has used Item 8.01 to report cash tender offers for its outstanding senior notes, and its director appointment filings state whether a new director is independent under Nasdaq rules and how the director compensation plan applies.
Micron Technology, Inc. (MU) – SEC Form 4 Insider Transaction
EVP of Global Operations Manish H. Bhatia reported the sale of 80,000 shares of Micron common stock on 30 June 2025. The weighted-average sale price disclosed in Column 4 was $123.16 per share, with individual trade prices ranging from $122.92 to $123.40.
Following the transaction, Bhatia’s direct beneficial ownership decreased to 275,067 shares. No derivative security transactions were reported, and the filing states that the shares were sold in multiple trades on the same day. The form was signed by attorney-in-fact Mai Lan Bui on 2 July 2025.
- Insider role: EVP, Global Operations (not a director or 10% owner).
- Value of shares sold (approx.): ~US$9.9 million (80,000 × $123.16).
- Remaining stake: 275,067 shares, indicating continued insider exposure.
The filing provides no commentary on motive, trading plan status, or company fundamentals. Investors typically monitor executive sales for potential signaling effects, but the transaction represents a small fraction of Micron’s ~1.1 billion shares outstanding and therefore has limited direct impact on company fundamentals.
Micron Technology, Inc. (MU) – Form 4 insider filing dated 06/30/2025
Director Teyin M. Liu reported a routine equity compensation event. The board granted the director 125 Restricted Stock Units (RSUs) at an exercise price of $0.00 in lieu of a cash retainer. The RSUs vested immediately on the grant date and, per the director’s deferral election, the underlying shares will be issued within 15 days after the director separates from service. Following the award, Liu reports 1,333 MU common shares held directly. No open-market purchase or sale price was involved, and there are no derivative disposals or additional transactions disclosed.
- Form type: 4 – Statement of Changes in Beneficial Ownership
- Insider role: Director (non-executive)
- Transaction code: “A” (acquisition) for RSUs granted
- Ownership form: Direct
The filing reflects standard director compensation and does not indicate any strategic change or material insider sentiment shift.
Micron Technology, Inc. (MU) – Form 144 filing: An unidentified insider has notified the SEC of an intent to sell up to 80,000 common shares. Based on the indicated price, the aggregate market value of the proposed sale is $9.85 million. The transaction will be executed through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 30 June 2025.
The shares derive from restricted-stock and performance-share grants received between April and October 2024. Micron reports 1.119 billion shares outstanding, so the proposed disposition represents roughly 0.007 % of the float. No sales by the filer occurred during the past three months, and the signer certifies that no undisclosed material adverse information is known.
This notice is procedural under Rule 144; consummation depends on market conditions and compliance with volume and manner-of-sale limits. Given the very small percentage of total shares, the filing is generally viewed as routine with limited market impact.